Array Biopharma Inc (NASDAQ:ARRY)

14.09
Delayed Data
As of Apr 20
 -0.35 / -2.42%
Today’s Change
6.73
Today|||52-Week Range
18.78
+10.08%
Year-to-Date
No recent news for Array Biopharma Inc.

Today’s Trading

Previous close14.44
Today’s open14.36
Day’s range14.08 - 14.65
Volume2,228,096
Average volume (3 months)3,585,011
Market cap$3.7B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-10.77%
Earnings growth (this year)-21.34%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+9.41%
P/E ratioNM
Price/Sales9.06
Price/Book263.66

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+0.19+0.51%
CBMCambrex Corp-0.05-0.09%
IPXLImpax Laboratories I...-0.30-1.49%
LXRXLexicon Pharmaceutic...+0.05+0.60%
Data as of 4:02pm ET, 04/20/2018

Financials

Next reporting dateMay 1, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$150.9M
Annual profit (last year)-$116.8M
Net profit margin-77.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts